Atlas Trials

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Clinical trial NCT06128460 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06128460
Sponsor
Obstetrics & Gynecology Hospital of Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2023-12-01
Primary completion
2025-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.